You searched for metabolic diseases - Page 12 of 64

RDEB recessive dystrophic epidermolysis bullosa skin blisters

News and Trends 21 Nov 2022

New Replay HSV gene therapy company Telaria to focus on skin diseases

Replay has announced the launch of Telaria, a herpes simplex virus (HSV) gene therapy company targeting rare skin diseases. It is the second of Replay’s product companies to leverage its…

November 21, 2022 - 3 minutesmins - By Jim Cornall

Opinion 12 Dec 2022

Artificial intelligence: a new era in rare genetic disease diagnosis

…Despite this progress, diagnosing rare genetic diseases often ends in inconclusive results. Current challenges in diagnosing rare genetic diseases Paradoxically, the strength and weakness of modern genome-based sequencing technologies is…

December 12, 2022 - 6 minutesmins - By External Contributor

Interview 28 Oct 2022

Migraines: a new vaccine frontier beyond infectious diseases

By bringing the efficiency and affordability of vaccines to chronic diseases such as migraines, U.S. company Vaxxinity aims to open a new frontier for vaccines in an effort to reach…

October 28, 2022 - 7 minutesmins - By Omnia Ibrahim

Best in Biotech 7 May 2024

Biotech in New Jersey: Nine companies leading the charge

…immunotherapies for cancer and infectious diseases using its proprietary Versamune platform. This platform is designed to enhance the body’s immune response against diseases by activating T cells in a way…

May 7, 2024 - 10 minutesmins - By Jules Adam

News and Trends 18 Jan 2017

Evotec launches New Biotech to tackle the Most Deadly Diseases

…in the new company, which will develop first-in-class therapeutics for fibrotic diseases. Fibrotic diseases, which include chronic kidney disease, liver fibrosis, systemic sclerosis, pulmonary fibrosis, myocardial infarction, stroke and cancer,…

January 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

orphazyme niemann pick type c disease rare metabolic disease molecules

News and Trends 30 Jan 2019

Danish Biotech’s Drug for Rare Metabolic Disease Aces Clinical Trial

A drug, developed by the Danish biotech Orphazyme for a rare metabolic disease, has shown promising results in a phase II/III trial, reducing the disease’s progression by 74%. The 50…

January 30, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 12 Dec 2024

Top biotech deals of November 2024

…earn up to $745 million in upfront and milestone payments. Finally, pharma giant Novo Nordisk continues its streak with the metabolic and heart diseases therapeutic field. It has tapped Ascendis…

December 12, 2024 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 6 Jun 2016

Swiss-US Implant could make taking pills obsolete in Autoimmune Diseases

…next generation of Intarcia’s implantable therapies, beyond ITCA 650. Intarcia’s subcutaneous implant for drug delivery (Credit: Intarcia) The developed antibodies are targeting metabolic, inflammatory and autoimmune diseases – key markets…

June 6, 2016 - 2 minutesmins - By Denise Neves Gameiro

In Depth 30 Dec 2020

A Look Back at the Past Decade of European Biotech

…this field seek to tackle aging-related diseases. Why is this so important? According to Alexandra Bause, a wide range of diseases can be attributed to aging. “In our 20s, 30s,…

December 30, 2020 - 15 minutesmins - By Karen O’Hanlon Cohrt

In Depth 26 Sep 2024

The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond

…SPECT to visualize biological processes within the body. These tracers often target specific biomarkers or metabolic pathways associated with diseases, especially cancer. Examples of commercially available radiotracers include fluorodeoxyglucose (FDG),…

September 26, 2024 - 14 minutesmins - By Jules Adam

News and Trends 12 Sep 2016

Grüßgott, get to Meet 9 exciting Biotechs from Vienna

…now started a Phase I trial. AFFiRiS is also developing novel vaccines, as immunotherapies to prevent cardiometabolic and neurodegenerative diseases chronic diseases. It was founded in 2003, and has recently…

September 12, 2016 - 6 minutesmins - By Denise Neves Gameiro

News and Trends 31 Aug 2022

Research shows TikoMed’s ILB has the potential to treat neurodegenerative diseases including ALS

…a variety of neuroinflammation-driven diseases, the low molecular weight dextran sulfate compound both mobilized and modulated naturally occurring tissue repair mechanisms and restored cellular homeostasis and function by releasing heparin-binding…

August 31, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

New Replay HSV gene therapy company Telaria to focus on skin diseases

Artificial intelligence: a new era in rare genetic disease diagnosis

Migraines: a new vaccine frontier beyond infectious diseases

Biotech in New Jersey: Nine companies leading the charge

Evotec launches New Biotech to tackle the Most Deadly Diseases

Danish Biotech’s Drug for Rare Metabolic Disease Aces Clinical Trial

Top biotech deals of November 2024

Swiss-US Implant could make taking pills obsolete in Autoimmune Diseases

A Look Back at the Past Decade of European Biotech

The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond

Grüßgott, get to Meet 9 exciting Biotechs from Vienna

Research shows TikoMed’s ILB has the potential to treat neurodegenerative diseases including ALS

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!